Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8968 |
High Similarity |
NPD3749 |
Approved |
0.8776 |
High Similarity |
NPD2344 |
Approved |
0.8654 |
High Similarity |
NPD7819 |
Suspended |
0.8618 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD3882 |
Suspended |
0.8543 |
High Similarity |
NPD2309 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8467 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8418 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8411 |
Intermediate Similarity |
NPD2800 |
Approved |
0.84 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8378 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8377 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8377 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8377 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8365 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8344 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8289 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8282 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8269 |
Intermediate Similarity |
NPD920 |
Approved |
0.8214 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.816 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8148 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8075 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8037 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8013 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7974 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7963 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7922 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7922 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD943 |
Approved |
0.7879 |
Intermediate Similarity |
NPD919 |
Approved |
0.7867 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7824 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7748 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7738 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7738 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7644 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7566 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7558 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7543 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD1470 |
Approved |
0.753 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5405 |
Approved |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7484 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7472 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD9717 |
Approved |
0.745 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7401 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7401 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7381 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7375 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7326 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD411 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD37 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD17 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7211 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD4749 |
Approved |
0.716 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7127 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD3269 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7108 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7076 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1252 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7016
|
Intermediate Similarity |
NPD7697 |
Approved |